How to buy Aeterna Zentaris stock | $0.88

Aeterna Zentaris Inc is a biotechnology business based in the US. Aeterna Zentaris shares (AEZS) are listed on the NASDAQ and all prices are listed in US Dollars. Aeterna Zentaris employs 12 staff and has a trailing 12-month revenue of around 0.00.

Aeterna Zentaris stock price (NASDAQ: AEZS)

Use our graph to track the performance of AEZS stocks over time.

Aeterna Zentaris shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$0.88
52-week range	$0.29 - $2.27
50-day moving average	$0.85
200-day moving average	$1.01
Wall St. target price	$4.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.75

Buy Aeterna Zentaris shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Aeterna Zentaris stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Aeterna Zentaris Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aeterna Zentaris price performance over time

Historical closes compared with the close of $0.88 from 2021-05-28

1 week (2021-07-21)	N/A
1 month (2021-07-01)	0.47%
3 months (2021-04-30)	-16.98%
6 months (2021-01-28)	N/A

1 year (2020-07-28)	N/A
2 years (2019-07-28)	N/A
3 years (2018-07-28)	N/A
5 years (2016-07-28)	N/A

Aeterna Zentaris financials

Revenue TTM	$3.1 million
Gross profit TTM	$1.3 million
Return on assets TTM	-6.77%
Return on equity TTM	-22.3%
Profit margin	-233.23%
Book value	$0.53
Market capitalisation	$87.9 million

TTM: trailing 12 months

Shorting Aeterna Zentaris shares

There are currently 4.6 million Aeterna Zentaris shares held short by investors – that's known as Aeterna Zentaris's "short interest". This figure is 2.1% up from 4.5 million last month.

There are a few different ways that this level of interest in shorting Aeterna Zentaris shares can be evaluated.

Aeterna Zentaris's "short interest ratio" (SIR)

Aeterna Zentaris's "short interest ratio" (SIR) is the quantity of Aeterna Zentaris shares currently shorted divided by the average quantity of Aeterna Zentaris shares traded daily (recently around 1.6 million). Aeterna Zentaris's SIR currently stands at 2.94. In other words for every 100,000 Aeterna Zentaris shares traded daily on the market, roughly 2940 shares are currently held short.

However Aeterna Zentaris's short interest can also be evaluated against the total number of Aeterna Zentaris shares, or, against the total number of tradable Aeterna Zentaris shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aeterna Zentaris's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Aeterna Zentaris shares in existence, roughly 40 shares are currently held short) or 0.0378% of the tradable shares (for every 100,000 tradable Aeterna Zentaris shares, roughly 38 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aeterna Zentaris.

Find out more about how you can short Aeterna Zentaris stock.

Aeterna Zentaris share dividends

We're not expecting Aeterna Zentaris to pay a dividend over the next 12 months.

Have Aeterna Zentaris's shares ever split?

Aeterna Zentaris's shares were split on a 1:100 basis on 19 November 2015. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aeterna Zentaris shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Aeterna Zentaris shares which in turn could have impacted Aeterna Zentaris's share price.

Aeterna Zentaris share price volatility

Over the last 12 months, Aeterna Zentaris's shares have ranged in value from as little as $0.29 up to $2.27. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aeterna Zentaris's is 2.2018. This would suggest that Aeterna Zentaris's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aeterna Zentaris overview

Aeterna Zentaris Inc. , a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen name. Aeterna Zentaris Inc. has a license agreement with Julius-Maximilians-University Wuerzburg for the development of an oral prophylactic bacterial vaccine against COVID-19 disease; development, manufacture, and commercialization of targeted immunosuppressive therapeutic proteins for the treatment of neuromyelitis optica spectrum disorder. It also has a license agreement with Consilient Health Ltd.

Frequently asked questions

What percentage of Aeterna Zentaris is owned by insiders or institutions?
Currently 0.085% of Aeterna Zentaris shares are held by insiders and 3.962% by institutions. How many people work for Aeterna Zentaris?
Latest data suggests 12 work at Aeterna Zentaris. When does the fiscal year end for Aeterna Zentaris?
Aeterna Zentaris's fiscal year ends in December. Where is Aeterna Zentaris based?
Aeterna Zentaris's address is: 315 Sigma Drive, Summerville, SC, United States, 29486 What is Aeterna Zentaris's ISIN number?
Aeterna Zentaris's international securities identification number is: CA0079754028 What is Aeterna Zentaris's CUSIP number?
Aeterna Zentaris's Committee on Uniform Securities Identification Procedures number is: 007975105